{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:06:04Z","timestamp":1792253164329,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.canlet.2021.09.037","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T23:35:17Z","timestamp":1633476917000},"page":"103-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Prostate cancer dormancy and recurrence"],"prefix":"10.1016","volume":"524","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0075-3745","authenticated-orcid":false,"given":"Frank C.","family":"Cackowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth I.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2021.09.037_bib1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.canlet.2021.09.037_bib2","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2021.09.037_bib3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2015.62.3504","article-title":"Annual hazard rates of recurrence for breast cancer during 24 Years of follow-up: results from the international breast cancer study group trials I to V","volume":"34","author":"Colleoni","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.09.037_bib4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2021.09.037_bib5","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.juro.2017.09.033","article-title":"Identification of recurrence sites following post-prostatectomy treatment for prostate cancer using (11)C-choline positron emission tomography and multiparametric pelvic magnetic resonance imaging","volume":"199","author":"Nehra","year":"2018","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2021.09.037_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0090-4295(02)02291-4","article-title":"Detection and isolation of prostate cancer cells from peripheral blood and bone marrow","volume":"61","author":"Ellis","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2021.09.037_bib7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.urolonc.2006.09.018","article-title":"The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer","volume":"25","author":"Pfitzenmaier","year":"2007","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.canlet.2021.09.037_bib8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-08-1754","article-title":"Disseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrence","volume":"15","author":"Morgan","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2021.09.037_bib9","first-page":"87","article-title":"Immunotherapeutic approaches directed against minimal residual cancer","volume":"31a","author":"Pantel","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2021.09.037_bib10","author":"Murray","year":"2012","journal-title":"Bone Marrow Res 2012"},{"key":"10.1016\/j.canlet.2021.09.037_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-319-97746-1_3","article-title":"Minimal residual disease in prostate cancer","volume":"1100","author":"Cackowski","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.canlet.2021.09.037_bib12","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1002\/1097-0142(19941101)74:9<2533::AID-CNCR2820740922>3.0.CO;2-D","article-title":"Identification of bone marrow micrometastases in patients with prostate cancer","volume":"74","author":"Wood","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2021.09.037_bib13","doi-asserted-by":"crossref","first-page":"8672","DOI":"10.1073\/pnas.84.23.8672","article-title":"Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies","volume":"84","author":"Schlimok","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2021.09.037_bib14","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/pros.23896","article-title":"Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer","volume":"79","author":"Cackowski","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2021.09.037_bib15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3793","article-title":"Mechanisms of disseminated cancer cell dormancy: an awakening field","volume":"14","author":"Sosa","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2021.09.037_bib16","first-page":"672","article-title":"The current paradigm and challenges ahead for the dormancy of disseminated tumor cells","volume":"1","author":"Risson","year":"2020","journal-title":"Nat. Can."},{"key":"10.1016\/j.canlet.2021.09.037_bib17","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/ncb2861","article-title":"TGF-beta2 dictates disseminated tumour cell fate in target organs through TGF-beta-RIII and p38alpha\/beta signalling","volume":"15","author":"Bragado","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2021.09.037_bib18","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1038\/ncomms7170","article-title":"NR2F1 controls tumour cell dormancy via SOX9- and RARbeta-driven quiescence programmes","volume":"6","author":"Sosa","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2021.09.037_bib19","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.18632\/oncotarget.2480","article-title":"Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways","volume":"5","author":"Chery","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2021.09.037_bib20","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1158\/0008-5472.CAN-14-0934","article-title":"Combined genome and transcriptome analysis of single disseminated cancer cells from bone marrow of prostate cancer patients reveals unexpected transcriptomes","volume":"74","author":"Guzvic","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2021.09.037_bib21","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050162","article-title":"Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone","volume":"21","author":"Owen","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.canlet.2021.09.037_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00109-015-1353-4","article-title":"The biology and clinical implications of prostate cancer dormancy and metastasis","volume":"94","author":"Morrissey","year":"2016","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.canlet.2021.09.037_bib23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10555-013-9422-z","article-title":"Dormancy in solid tumors: implications for prostate cancer","volume":"32","author":"Ruppender","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2021.09.037_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41467-017-02674-y","article-title":"Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma","volume":"9","author":"Werner-Klein","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2021.09.037_bib25","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI43414","article-title":"Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow","volume":"121","author":"Shiozawa","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2021.09.037_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41580-019-0103-9","article-title":"Haematopoietic stem cell activity and interactions with the niche","volume":"20","author":"Pinho","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2021.09.037_bib27","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1084\/jem.20110840","article-title":"Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone","volume":"208","author":"Kobayashi","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2021.09.037_bib28","doi-asserted-by":"crossref","first-page":"19351","DOI":"10.1074\/jbc.M116.737379","article-title":"Secreted protein acidic and rich in cysteine (SPARC) mediates metastatic dormancy of prostate cancer in bone","volume":"291","author":"Sharma","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2021.09.037_bib29","doi-asserted-by":"crossref","first-page":"36520","DOI":"10.1038\/srep36520","article-title":"Axl is required for TGF-beta2-induced dormancy of prostate cancer cells in the bone marrow","volume":"6","author":"Yumoto","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2021.09.037_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1593\/neo.91384","article-title":"GAS6\/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche","volume":"12","author":"Shiozawa","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2021.09.037_bib31","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/jcb.25582","article-title":"Growth arrest-specific 6 (GAS6) promotes prostate cancer survival by G1 arrest\/S phase delay and inhibition of apoptosis during chemotherapy in bone marrow","volume":"117","author":"Lee","year":"2016","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2021.09.037_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061873","article-title":"GAS6 receptor status is associated with dormancy and bone metastatic tumor formation","volume":"8","author":"Taichman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2021.09.037_bib33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/jcb.25768","article-title":"Mer tyrosine kinase regulates disseminated prostate cancer cellular dormancy","volume":"118","author":"Cackowski","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2021.09.037_bib34","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/1541-7786.MCR-17-0132","article-title":"Sympathetic signaling reactivates quiescent disseminated prostate cancer cells in the bone marrow","volume":"15","author":"Decker","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2021.09.037_bib35","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1084\/jem.20180661","article-title":"Wnt5a induces and maintains prostate cancer cells dormancy in bone","volume":"216","author":"Ren","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2021.09.037_bib36","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1158\/0008-5472.CAN-04-0113","article-title":"Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth","volume":"64","author":"Aguirre-Ghiso","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2021.09.037_bib37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neo.2020.11.009","article-title":"Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow","volume":"23","author":"Jung","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2021.09.037_bib38","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(20)31952-8","article-title":"Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data","volume":"396","author":"Vale","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2021.09.037_bib39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(06)70700-8","article-title":"Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy","volume":"7","author":"Messing","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2021.09.037_bib40","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1056\/NEJMoa0810095","article-title":"Duration of androgen suppression in the treatment of prostate cancer","volume":"360","author":"Bolla","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2021.09.037_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1470-2045(18)30757-5","volume":"20","author":"Denham","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2021.09.037_bib42","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1200\/JCO.2017.76.4126","article-title":"Phase III intergroup trial of adjuvant androgen deprivation with or without mitoxantrone plus prednisone in patients with high-risk prostate cancer after radical prostatectomy: SWOG S9921","volume":"36","author":"Hussain","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.09.037_bib43","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1002\/cncr.28270","article-title":"Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): important lessons for future trials","volume":"119","author":"Schweizer","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2021.09.037_bib44","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1200\/JCO.18.02158","article-title":"Effect of chemotherapy with docetaxel with androgen suppression and radiotherapy for localized high-risk prostate cancer: the randomized phase III NRG Oncology RTOG 0521 trial","volume":"37","author":"Rosenthal","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.09.037_bib45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1200\/JCO.2020.38.6_suppl.333","article-title":"Adjuvant docetaxel for high-risk localized prostate cancer: update of NRG Oncology\/RTOG 0521","volume":"38","author":"Sandler","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2021.09.037_bib46","series-title":"A Pilot Study of 5-AZA and ATRA for Prostate Cancer with PSA-Only Recurrence after Local Treatment. NIH","year":"2021"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521004985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521004985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:59:57Z","timestamp":1759593597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383521004985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":46,"alternative-id":["S0304383521004985"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2021.09.037","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate cancer dormancy and recurrence","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2021.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}